Clinical Radiology
Volume 65, Issue 7 , Pages 500-516 , July 2010

Molecular imaging: current status and emerging strategies

  • M.A. Pysz

      Affiliations

    • Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USA
    • ,
  • S.S. Gambhir

      Affiliations

    • Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USA
    • Departments of Bioengineering and Materials Science and Engineering, Stanford University, Stanford, CA, USA
    • ,
  • J.K. Willmann

      Affiliations

    • Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USA
    • Corresponding Author InformationGuarantor and correspondent: J. K. Willmann, Department of Radiology, Stanford University School of Medicine, 300 Pasteur Drive, Room H1307, Stanford, CA 94305 5424, USA. Tel.: +1 650 723 5424; fax: +1 650 723 1909.

Received 12 March 2010 ,Accepted 25 March 2010.

References 

  1. Mankoff DA. A definition of molecular imaging. J Nucl Med. 2007;48(6):18N–21N
  2. Peterson TE, Manning HC. Molecular imaging: 18F-FDG PET and a whole lot more. J Nucl Med Technol. 2009;37(3):151–161
  3. Hoffman JM, Gambhir SS. Molecular imaging: the vision and opportunity for radiology in the future. Radiology. 2007;244(1):39–47
  4. Massoud TF, Gambhir SS. Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm. Trends Mol Med. 2007;13(5):183–191
  5. Wong ST. Emerging treatment combinations: integrating therapy into clinical practice. Am J Health Syst Pharm. 2009;66(23 Suppl 6):S9–S14
  6. Blanco E, Kessinger CW, Sumer BD, et al. Multifunctional micellar nanomedicine for cancer therapy. Exp Biol Med (Maywood). 2009;234(2):123–131
  7. Desar IM, van Herpen CM, van Laarhoven HW, et al. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy. Cancer Treat Rev. 2009;35(4):309–321
  8. Lucignani G. Monitoring cancer therapy with PET: probably effective, but more research is needed. Eur J Nucl Med Mol Imaging. 2009;36(9):1520–1525
  9. Serkova NJ, Hasebroock KM, Kraft SL. Magnetic resonance spectroscopy of living tissues. Methods Mol Biol. 2009;520:315–327
  10. Soares DP, Law M. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol. 2009;64(185 Pt 2):167–223
  11. van der Graaf M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J. 2009;39(4):527–540
  12. De Stefano N, Filippi M, Miller D, et al. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology. 2007;69(20):1942–1952
  13. Boesch C. Musculoskeletal spectroscopy. J Magn Reson Imaging. 2007;25(2):321–338
  14. Kim HL. Optical imaging in oncology. Urol Oncol. 2009;27(3):298–300
  15. Konig K. Clinical multiphoton tomography. J Biophotonics. 2008;1(1):13–23
  16. Chen J, Lee L. Clinical applications and new developments of optical coherence tomography: an evidence-based review. Clin Exp Optom. 2007;90(5):317–335
  17. Zysk AM, Nguyen FT, Oldenburg AL, et al. Optical coherence tomography: a review of clinical development from bench to bedside. J Biomed Opt. 2007;12(5):051403
  18. Contag CH. In vivo pathology: seeing with molecular specificity and cellular resolution in the living body. Annu Rev Pathol. 2007;2:277–305
  19. Wang TD, Friedland S, Sahbaie P, et al. Functional imaging of colonic mucosa with a fibered confocal microscope for real-time in vivo pathology. Clin Gastroenterol Hepatol. 2007;5(11):1300–1305
  20. Konig K, Weinigel M, Hoppert D, et al. Multiphoton tissue imaging using high-NA microendoscopes and flexible scan heads for clinical studies and small animal research. J Biophotonics. 2008;1(6):506–513
  21. Robert B. Resonance Raman spectroscopy. Photosyn Res. 2009;101(2-3):147–155
  22. Wachsmann-Hogiu S, Weeks T, Huser T. Chemical analysis in vivo and in vitro by Raman spectroscopy—from single cells to humans. Curr Opin Biotechnol. 2009;20(1):63–73
  23. Motz JT, Fitzmaurice M, Miller A, et al. In vivo Raman spectral pathology of human atherosclerosis and vulnerable plaque. J Biomed Opt. 2006;11(2):021003
  24. Haka AS, Volynskaya Z, Gardecki JA, et al. In vivo margin assessment during partial mastectomy breast surgery using Raman spectroscopy. Cancer Res. 2006;66(6):3317–3322
  25. Huang Z, Teh SK, Zheng W, et al. Integrated Raman spectroscopy and trimodal wide-field imaging techniques for real-time in vivo tissue Raman measurements at endoscopy. Opt Lett. 2009;34(6):758–760
  26. Kim DE, Kim JY, Schellingerhout D, et al. Protease imaging of human atheromata captures molecular information of atherosclerosis, complementing anatomic imaging. Arterioscler Thromb Vasc Biol. 2010;30(3):449–456
  27. Deshpande N, Needles A, Willmann JK. Molecular ultrasound imaging: current status and future directions. Clinical Radiology. 2010;
  28. George A, Movahed A. Cardiac computed tomography: current practice and future applications. Rev Cardiovasc Med. 2009;10(2):97–105
  29. Weskott HP. Emerging roles for contrast-enhanced ultrasound. Clin Hemorheol Microcirc. 2008;40(1):51–71
  30. Celli N, Gaiani S, Piscaglia F, et al. Characterization of liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol. 2007;19(1):3–14
  31. Wilson SR, Jang HJ, Kim TK, et al. Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. AJR Am J Roentgenol. 2008;190(3):691–695
  32. Pochon S, Tardy I, Bussat P, et al. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol. 2010;45(2):89–95
  33. Pysz MA, Foygel K, Rosenberg J, et al. Antiangiogenic cancer therapy: Monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology (2010), doi:10.1148/radiol.10091858.
  34. Willmann JK, van Bruggen N, Dinkelborg LM, et al. Molecular imaging in drug development. Nat Rev Drug Discov. 2008;7(7):591–607
  35. Agdeppa ED, Spilker ME. A review of imaging agent development. AAPS J. 2009;11(2):286–299
  36. Alencar H, Funovics MA, Figueiredo J, et al. Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection—study in mice. Radiology. 2007;244(1):232–238
  37. Gounaris E, Tung CH, Restaino C, et al. Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth. PLoS One. 2008;3(8):e2916
  38. Figueiredo JL, Alencar H, Weissleder R, et al. Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer. Int J Cancer. 2006;118(11):2672–2677
  39. Jaffer FA, Vinegoni C, John MC, et al. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation. 2008;118(18):1802–1809
  40. Weissleder R, Tung CH, Mahmood U, et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol. 1999;17(4):375–378
  41. Pierce MC, Javier DJ, Richards-Kortum R. Optical contrast agents and imaging systems for detection and diagnosis of cancer. Int J Cancer. 2008;123(9):1979–1990
  42. Hsiung PL, Hardy J, Friedland S, et al. Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat Med. 2008;14(4):454–458
  43. Liu JT, Helms MW, Mandella MJ, et al. Quantifying cell-surface biomarker expression in thick tissues with ratiometric three-dimensional microscopy. Biophys J. 2009;96(6):2405–2414
  44. Zavaleta C, de la Zerda A, Liu Z, et al. Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes. Nano Lett. 2008;8(9):2800–2805
  45. Kneipp J, Kneipp H, Kneipp K. SERS—a single-molecule and nanoscale tool for bioanalytics. Chem Soc Rev. 2008;37(5):1052–1060
  46. Zavaleta CL, Smith BR, Walton I, et al. Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy. Proc Natl Acad Sci U S A. 2009;106(32):13511–13516
  47. Muller M, Zumbusch A. Coherent anti-stokes Raman scattering microscopy. Chemphyschem. 2007;8(15):2156–2170
  48. De la Zerda A, Zavaleta C, Keren S, et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol. 2008;3(9):557–562
  49. Dijkstra RJ, Scheenen WJ, Dam N, et al. Monitoring neurotransmitter release using surface-enhanced Raman spectroscopy. J Neurosci Methods. 2007;159:
  50. Wang Z, Bonoiu A, Samoc M, et al. Biological pH sensing based on surface enhanced Raman scattering through a 2-aminothiophenol-silver probe. Biosens Bioelectron. 2008;23(6):886–891
  51. Evans CL, Potma EO, Puoris’haag M, et al. Chemical imaging of tissue in vivo with video-rate coherent anti-stokes Raman scattering microscopy. Proc Natl Acad Sci U S A. 2005;102(46):16807–16812
  52. Huff TB, Cheng JX. In vivo coherent anti-stokes Raman scattering imaging of sciatic nerve tissue. J Microsc. 2007;225(Pt 2):175–182
  53. Kaufmann BA. Ultrasound molecular imaging of atherosclerosis. Cardiovasc Res. 2009;83(4):617–625
  54. Lindner JR. Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol. 2009;6(7):475–481
  55. Hwang M, Niermann KJ, Lyshchik A, et al. Sonographic assessment of tumor response: from in vivo models to clinical applications. Ultrasound Q. 2009;25(4):175–183
  56. Strobel D, Seitz K, Blank W, et al. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med. 2009;30(4):376–382
  57. Kaufmann BA, Sanders JM, Davis C, et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation. 2007;116(3):276–284
  58. Lindner JR. Contrast ultrasound molecular imaging of inflammation in cardiovascular disease. Cardiovasc Res. 2009;84(2):182–189
  59. Klibanov AL. Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging. Med Biol Eng Comput. 2009;47(8):875–882
  60. Marshall D, Pedley RB, Boden JA, et al. Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody. Br J Cancer. 1996;73(5):565–572
  61. Willmann JK, Lutz AM, Paulmurugan R, et al. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology. 2008;248(3):936–944
  62. Willmann JK, Paulmurugan R, Chen K, et al. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology. 2008;246(2):508–518
  63. Palmowski M, Huppert J, Ladewig G, et al. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther. 2008;7(1):101–109
  64. Korpanty G, Carbon JG, Grayburn PA, et al. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res. 2007;13(1):323–330
  65. Lee DJ, Lyshchik A, Huamani J, et al. Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model. J Ultrasound Med. 2008;27(6):855–866
  66. Rychak JJ, Graba J, Cheung AM, et al. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Mol Imaging. 2007;6(5):289–296
  67. Lyshchik A, Fleischer AC, Huamani J, et al. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography. J Ultrasound Med. 2007;26(11):1575–1586
  68. Willmann JK, Kimura RH, Deshpande N, et al. Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides. J Nucl Med. 2010;51(3):433–440
  69. Bachmann C, Klibanov AL, Olson TS, et al. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn’s disease. Gastroenterology. 2006;130(1):8–16
  70. Kaufmann BA, Carr CL, Belcik JT, et al. Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arterioscler Thromb Vasc Biol. 2010;30(1):54–59
  71. Barreiro O, Aguilar RJ, Tejera E, et al. Specific targeting of human inflamed endothelium and in situ vascular tissue transfection by the use of ultrasound contrast agents. JACC Cardiovasc Imaging. 2009;2(8):997–1005
  72. Reinhardt M, Hauff P, Linker RA, et al. Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by sensitive particle acoustic quantification (SPAQ). Neuroimage. 2005;27(2):267–268
  73. Weller GE, Lu E, Csikari MM, et al. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation. 2003;108(2):218–224
  74. Kaufmann BA, Lewis C, Xie A, et al. Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. Eur Heart J. 2007;28(16):2011–2017
  75. Lindner JR, Song J, Christiansen J, et al. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation. 2001;104(17):2107–2112
  76. Villanueva FS, Lu E, Bowry S, et al. Myocardial ischemic memory imaging with molecular echocardiography. Circulation. 2007;115(3):345–352
  77. Bell AG. The production of sound by radiant energy. Science. 1881;2(49):242–253
  78. Li C, Wang LV. Photoacoustic tomography and sensing in biomedicine. Phys Med Biol. 2009;54(19):R58–R97
  79. Wang LV. Prospects of photoacoustic tomography. Med Phys. 2008;35:
  80. Razansky D, Baeten J, Ntziachristos V. Sensitivity of molecular target detection by multispectral optoacoustic tomography (MSOT). Med Phys. 2009;36(3):939–945
  81. Yang X, Stein EW, Ashkenazi S, et al. Nanoparticles for photoacoustic imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1(4):360–368
  82. Jin X, Li C, Wang LV. Effects of acoustic heterogeneities on transcranial brain imaging with microwave-induced thermoacoustic tomography. Med Phys. 2008;35(7):3205–3214
  83. Mehrmohammadi M, Oh J, Aglyamov SR, et al. Pulsed magneto-acoustic imaging. Conf Proc IEEE Eng Med Biol Soc. 2009;1:4771–4774
  84. Qu M, Mallidi S, Mehrmohammadi M, et al. Combined photoacoustic and magneto-acoustic imaging. Conf Proc IEEE Eng Med Biol Soc. 2009;1:4763–4766
  85. Zharov VP, Galanzha EI, Tuchin VV. In vivo photothermal flow cytometry: imaging and detection of individual cells in blood and lymph flow. J Cell Biochem. 2006;97(5):916–932
  86. Fang H, Maslov K, Wang LV. Photoacoustic Doppler effect from flowing small light-absorbing particles. Phys Rev Lett. 2007;99(18):184501
  87. Fang H, Wang LV. M-mode photoacoustic particle flow imaging. Opt Lett. 2009;34(5):671–673
  88. Zhang E, Laufer J, Beard P. Backward-mode multiwavelength photoacoustic scanner using a planar Fabry–Perot polymer film ultrasound sensor for high-resolution three-dimensional imaging of biological tissues. Appl Opt. 2008;47(4):561–577
  89. Shah J, Aglyamov SR, Sokolov K, et al. Ultrasound imaging to monitor photothermal therapy — feasibility study. Opt Express. 2008;16(6):3776–3785
  90. Shah J, Park S, Aglyamov S, et al. Photoacoustic imaging and temperature measurement for photothermal cancer therapy. J Biomed Opt. 2008;13:
  91. Ashkenazi S, Huang SW, Horvath T, et al. Photoacoustic probing of fluorophore excited state lifetime with application to oxygen sensing. J Biomed Opt. 2008;13(3):034023
  92. Horvath TD, Kim G, Kopelman R, et al. Ratiometric photoacoustic sensing of pH using a “sonophore”. Analyst. 2008;133(6):747–749
  93. Bouchard LS, Anwar MS, Liu GL, et al. Picomolar sensitivity MRI and photoacoustic imaging of cobalt nanoparticles. Proc Natl Acad Sci U S A. 2009;106(11):4085–4089
  94. Buck SM, Koo YE, Park E, et al. Optochemical nanosensor PEBBLEs: photonic explorers for bioanalysis with biologically localized embedding. Curr Opin Chem Biol. 2004;8(5):540–546
  95. Buck SM, Xu H, Brasuel M, et al. Nanoscale probes encapsulated by biologically localized embedding (PEBBLEs) for ion sensing and imaging in live cells. Talanta. 2004;63(1):41–59
  96. Yang JM, Maslov K, Yang HC, et al. Photoacoustic endoscopy. Opt Lett. 2009;34(10):1591–1593
  97. Fadeel B, Garcia-Bennett AE. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev. 2009;62(3):362–374
  98. Willmann JK, Cheng Z, Davis C, et al. Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. Radiology. 2008;249(1):212–219
  99. Cavaliere F, Volpe C, Gargaruti R, et al. Effects of acute hypoventilation and hyperventilation on exhaled carbon monoxide measurement in healthy volunteers. BMC Pulm Med. 2009;9:51
  100. Weight RM, Dale PS, Viator JA. Detection of circulating melanoma cells in human blood using photoacoustic flowmetry. Conf Proc IEEE Eng Med Biol Soc. 2009;1:106–109
  101. Ermilov SA, Khamapirad T, Conjusteau A, et al. Laser optoacoustic imaging system for detection of breast cancer. J Biomed Opt. 2009;14(2):024007
  102. Manohar S, Vaartjes SE, van Hespen JC, et al. Initial results of in vivo non-invasive cancer imaging in the human breast using near-infrared photoacoustics. Opt Express. 2007;15(19):12277–12285
  103. Keren S, Zavaleta C, Cheng Z, et al. Noninvasive molecular imaging of small living subjects using Raman spectroscopy. Proc Natl Acad Sci U S A. 2008;105(15):5844–5849
  104. Song KH, Kim C, Maslov K, et al. Noninvasive in vivo spectroscopic nanorod-contrast photoacoustic mapping of sentinel lymph nodes. Eur J Radiol. 2009;70(2):227–231
  105. Sinusas AJ, Bengel F, Nahrendorf M, et al. Multimodality cardiovascular molecular imaging, part I. Circ Cardiovasc Imaging. 2008;1(3):244–256
  106. Ng CS, Wang X, Faria SC, et al. Perfusion CT in patients with metastatic renal cell carcinoma treated with interferon. AJR Am J Roentgenol. 2010;194(1):166–171
  107. Margolis DJ, Hoffman JM, Herfkens RJ, et al. Molecular imaging techniques in body imaging. Radiology. 2007;245(2):333–356
  108. Goldsmith SJ. Radioimmunotherapy of lymphoma: bexxar and zevalin. Semin Nucl Med. 2010;40(2):122–135
  109. Mariani G, Bruselli L, Kuwert T, et al. A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging. 2010;
  110. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348(25):2491–2499
  111. Harisinghani MG, Jhaveri KS, Weissleder R, et al. MRI contrast agents for evaluating focal hepatic lesions. Clin Radiol. 2001;56(9):714–725
  112. Al-Mallah M, Kwong RY. Clinical application of cardiac CMR. Rev Cardiovasc Med. 2009;10(3):134–141
  113. Blamek S, Larysz D, Ficek K, et al. MR spectroscopic evaluation of brain tissue damage after treatment for pediatric brain tumors. Acta Neurochir Suppl. 2010;106:183–186
  114. Modrego PJ, Pina MA, Fayed N, et al. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer’s disease: a nonrandomised controlled trial with magnetic resonance spectroscopy. CNS Drugs. 2006;20(10):867–877
  115. Schnell GB, Kryski AJ, Mann L, et al. Contrast echocardiography accurately predicts myocardial perfusion before angiography during acute myocardial infarction. Can J Cardiol. 2007;23(13):1043–1048
  116. Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005;111(12):1551–1555
  117. Lieber CA, Majumder SK, Ellis DL, et al. In vivo nonmelanoma skin cancer diagnosis using Raman microspectroscopy. Lasers Surg Med. 2008;40(7):461–467
  118. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003;17(5):545–580
  119. Mercer JR. Molecular imaging agents for clinical positron emission tomography in oncology other than fluorodeoxyglucose (FDG): applications, limitations and potential. J Pharm Pharm Sci. 2007;10(2):180–202
  120. Dunphy MP, Lewis JS. Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET. J Nucl Med. 2009;50(Suppl. 1):106S–121S
  121. Mittra E, Quon A. Positron emission tomography/computed tomography: the current technology and applications. Radiol Clin North Am. 2009;47(1):147–160
  122. Lalonde L, Ziadi MC, Beanlands R. Cardiac positron emission tomography: current clinical practice. Cardiol Clin. 2009;27(2):237–255
  123. Wang J, Maurer L. Positron emission tomography: applications in drug discovery and drug development. Curr Top Med Chem. 2005;5(11):1053–1075
  124. Parsey RV, Mann JJ. Applications of positron emission tomography in psychiatry. Semin Nucl Med. 2003;33(2):129–135
  125. Pantaleo MA, Nannini M, Maleddu A, et al. Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Cancer Treat Rev. 2008;34(2):103–121
  126. Josephs D, Spicer J, O’Doherty M. Molecular imaging in clinical trials. Target Oncol. 2009;4(3):151–168
  127. Liu S. The role of coordination chemistry in the development of target-specific radiopharmaceuticals. Chem Soc Rev. 2004;33(7):445–461
  128. Lampl Y, Lorberboym M, Blankenberg FG, et al. Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia. Neurology. 2006;66(8):1253–1254
  129. Burtscher IM, Holtas S. Proton MR spectroscopy in clinical routine. J Magn Reson Imaging. 2001;13(4):560–567
  130. Beloueche-Babari M, Chung YL, Al-Saffar NM, et al. Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy. Br J Cancer. 2010;102(1):1–7
  131. Kurhanewicz J, Bok R, Nelson SJ, et al. Current and potential applications of clinical 13C MR spectroscopy. J Nucl Med. 2008;49(3):341–344
  132. Molckovsky A, Song LM, Shim MG, et al. Diagnostic potential of near-infrared Raman spectroscopy in the colon: differentiating adenomatous from hyperplastic polyps. Gastrointest Endosc. 2003;57(3):396–402
  133. Blankenberg FG. In vivo imaging of apoptosis. Cancer Biol Ther. 2008;7(10):1525–1532
  134. Gangloff A, Hsueh WA, Kesner AL, et al. Estimation of paclitaxel biodistribution and uptake in human-derived xenografts in vivo with (18)F-fluoropaclitaxel. J Nucl Med. 2005;46(11):1866–1871
  135. van Tilborg GA, Mulder WJ, Chin PT, et al. Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. Bioconjug Chem. 2006;17(4):865–868
  136. Yu KN, Lee SM, Han JY, et al. Multiplex targeting, tracking, and imaging of apoptosis by fluorescent surface enhanced Raman spectroscopic dots. Bioconjug Chem. 2007;18(4):1155–1162
  137. Mishani E, Hagooly A. Strategies for molecular imaging of epidermal growth factor receptor tyrosine kinase in cancer. J Nucl Med. 2009;50(8):1199–1202
  138. Mankoff DA, Link JM, Linden HM, et al. Tumor receptor imaging. J Nucl Med. 2008;49(Suppl. 2):149S–163S
  139. Xu N, Cai G, Ye W, et al. Molecular imaging application of radioiodinated anti-EGFR human Fab to EGFR-overexpressing tumor xenografts. Anticancer Res. 2009;29(10):4005–4011
  140. Li PC, Wang CR, Shieh DB, et al. In vivo photoacoustic molecular imaging with simultaneous multiple selective targeting using antibody-conjugated gold nanorods. Opt Express. 2008;16(23):18605–18615
  141. Kah JC, Kho KW, Lee CG, et al. Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles. Int J Nanomedicine. 2007;2(4):785–798
  142. Niu G, Cai W, Chen X. Molecular imaging of human epidermal growth factor receptor 2 (HER-2) expression. Front Biosci. 2008;13:790–805
  143. Bhattacharyya S, Wang S, Reinecke D, et al. Synthesis and evaluation of near-infrared (NIR) dye-herceptin conjugates as photoacoustic computed tomography (PCT) probes for HER2 expression in breast cancer. Bioconjug Chem. 2008;19(6):1186–1193
  144. Sha MY, Xu H, Natan MJ, et al. Surface-enhanced Raman scattering tags for rapid and homogeneous detection of circulating tumor cells in the presence of human whole blood. J Am Chem Soc. 2008;130(51):17214–17215
  145. Kang B, Yu D, Dai Y, et al. Cancer-cell targeting and photoacoustic therapy using carbon nanotubes as “bomb” agents. Small. 2009;5(11):1292–1301
  146. Ljungkvist AS, Bussink J, Kaanders JH, et al. Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers. Radiat Res. 2007;167(2):127–145
  147. Reischl G, Dorow DS, Cullinane C, et al. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA—first small animal PET results. J Pharm Pharm Sci. 2007;10(2):203–211
  148. Krohn KA, Link JM, Mason RP. Molecular imaging of hypoxia. J Nucl Med. 2008;49(Suppl. 2):129S–48S
  149. Lungu GF, Li ML, Xie X, et al. In vivo imaging and characterization of hypoxia-induced neovascularization and tumor invasion. Int J Oncol. 2007;30(1):45–54
  150. Shah NC, Lyandres O, Walsh JT, et al. Lactate and sequential lactate-glucose sensing using surface-enhanced Raman spectroscopy. Anal Chem. 2007;79(18):6927–6932
  151. Cai W, Chen X. Multimodality molecular imaging of tumor angiogenesis. J Nucl Med. 2008;49(Suppl. 2):113S–128S
  152. Cai W, Gambhir SS, Chen X. Molecular imaging of tumor vasculature. Methods Enzymol. 2008;445:[Chapter 7]:141–176
  153. Miao Z, Ren G, Liu H, et al. An engineered knottin peptide labeled with 18F for PET imaging of integrin expression. Bioconjug Chem. 2009;20(12):2342–2347
  154. Wang L, Xie X, Oh JT, et al. Combined photoacoustic and molecular fluorescence imaging in vivo. Conf Proc IEEE Eng Med Biol Soc. 2005;1:190–192
  155. von Forstner C, Egberts JH, Ammerpohl O, et al. Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer. J Nucl Med. 2008;49(8):1362–1370
  156. Cheng Z, Levi J, Xiong Z, et al. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjug Chem. 2006;17(3):662–669
  157. Scherer RL, McIntyre JO, Matrisian LM. Imaging matrix metalloproteinases in cancer. Cancer Metastasis Rev. 2008;27(4):679–690
  158. Wagner S, Breyholz HJ, Faust A, et al. Molecular imaging of matrix metalloproteinases in vivo using small molecule inhibitors for SPECT and PET. Curr Med Chem. 2006;13(23):2819–2838
  159. Jastrzebska B, Lebel R, Therriault H, et al. New enzyme-activated solubility-switchable contrast agent for magnetic resonance imaging: from synthesis to in vivo imaging. J Med Chem. 2009;52(6):1576–1581
  160. Elsasser-Beile U, Reischl G, Wiehr S, et al. PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen. J Nucl Med. 2009;50(4):606–611
  161. Hillier SM, Maresca KP, Femia FJ, et al. Preclinical evaluation of novel glutamate–urea–lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Res. 2009;69(17):6932–6940
  162. Kularatne SA, Zhou Z, Yang J, et al. Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted (99 m)Tc-radioimaging agents. Mol Pharm. 2009;6(3):790–800
  163. Serda RE, Adolphi NL, Bisoffi M, et al. Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging. Mol Imaging. 2007;6(4):277–288
  164. Chen Y, Dhara S, Banerjee SR, et al. A low molecular weight PSMA-based fluorescent imaging agent for cancer. Biochem Biophys Res Commun. 2009;390(3):624–629
  165. Gao X, Cui Y, Levenson RM, et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol. 2004;22(8):969–976
  166. Gilad AA, Ziv K, McMahon MT, et al. MRI reporter genes. J Nucl Med. 2008;49(12):1905–1908
  167. Serganova I, Mayer-Kukuck P, Huang R, et al. Molecular imaging: reporter gene imaging. Handb Exp Pharmacol. 2008;185(Pt 2):167–223
  168. Li L, Zhang HF, Zemp RJ, et al. Simultaneous imaging of a lacZ-marked tumor and microvasculature morphology in vivo by dual-wavelength photoacoustic microscopy. J Innov Opt Health Sci. 2008;1(2):207–215

PII: S0009-9260(10)00178-9

doi: 10.1016/j.crad.2010.03.011

Clinical Radiology
Volume 65, Issue 7 , Pages 500-516 , July 2010

Article Tools

* Image Usage & Resolution